influenza
Simple HealthKit Raises $8M in Series A Round
The California startup sells PCR-based tests for respiratory and sexually transmitted diseases and said it will use the funding toward innovation and expanded sales of its products.
MedMira Gets CE Mark for COVID, Flu Combo Assay
The test is designed to detect SARS-CoV-2 and influenza A and B in a single nasal swab, according to the Canadian company.
Visby Medical Nabs FDA EUA for POC Respiratory Panel Test
The assay detects and differentiates between SARS-CoV-2, influenza A, and influenza B in nasopharyngeal swab specimens.
FDA Grants EUAs to Lucira Health Molecular COVID/Flu Test; Azure Biotech, CorDx COVID Antigen Tests
FDA said Lucira's test is the first molecular COVID-19 test to receive FDA authorization following collaboration with NIH's Independent Test Assessment program.
At the AMP annual meeting this week, the company outlined its technology and vision for a speedy, low-cost, high-accuracy diagnostic.